Palo Alto, CA, United States of America

Elissa P Sena


Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 399(Granted Patents)


Company Filing History:


Years Active: 1993-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Elissa P Sena: Innovator in Eukaryotic Cell Targeting

Introduction

Elissa P Sena is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of genetic engineering, particularly in the area of eukaryotic cell targeting. With a total of 7 patents to her name, her work has paved the way for advancements in genetic modification techniques.

Latest Patents

Elissa's latest patents focus on methods for targeting exogenous polynucleotides to predetermined endogenous DNA sequences in eukaryotic cells. One of her notable inventions, "Homologous sequence targeting in eukaryotic cells," describes techniques for altering endogenous DNA sequences through targeted homologous recombination. This invention emphasizes the importance of generating DNA sequence-specific targeting of chemical substituents within metabolically active eukaryotic cells. Additionally, her work includes compositions that incorporate exogenous targeting polynucleotides, complementary pairs, and recombinase proteins, which are essential for the methods she has developed.

Career Highlights

Throughout her career, Elissa has worked with esteemed organizations such as Daikin Industries, Ltd. and SRI International. Her experience in these companies has contributed to her expertise in the field of genetic engineering and biotechnology.

Collaborations

Elissa has collaborated with notable individuals in her field, including David A Zarling and Cornelia J Calhoun. These partnerships have further enhanced her research and development efforts.

Conclusion

Elissa P Sena's innovative work in eukaryotic cell targeting has significantly impacted the field of genetic engineering. Her patents and collaborations reflect her dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…